REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment
14/01/2021 11:20
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210114:nBw9h8k1ra&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment
Ap19
FORM 8.3 - Amendment to Purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 11 January 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
2,785,376 2.16% 680,874 0.53%
(2) Derivatives (other than options):
354,221 0.27% 604,791 0.47%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL:
3,139,597 2.44% 1,285,665 1.00%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 12 203.1120 USD
Purchase 31 199.8000 USD
Purchase 45 202.9550 USD
Purchase 74 199.5500 USD
Purchase 100 199.5900 USD
Purchase 100 203.5575 USD
Purchase 100 203.1100 USD
Purchase 100 203.0300 USD
Purchase 100 202.8200 USD
Purchase 100 200.3700 USD
Purchase 100 199.7600 USD
Purchase 116 203.6224 USD
Purchase 120 200.5333 USD
Purchase 200 200.5050 USD
Purchase 200 199.5950 USD
Purchase 202 199.8326 USD
Purchase 209 203.5156 USD
Purchase 228 200.5430 USD
Purchase 328 200.3384 USD
Purchase 351 199.7570 USD
Purchase 390 199.9289 USD
Purchase 457 199.9140 USD
Purchase 485 203.4359 USD
Purchase 520 200.0726 USD
Purchase 625 200.0232 USD
Purchase 700 203.5389 USD
Purchase 1,000 199.7155 USD
Purchase 1,010 199.7740 USD
Purchase 1,218 200.1866 USD
Purchase 3,212 199.2300 USD
Purchase 4,134 200.0881 USD
Purchase 4,242 200.1138 USD
Purchase 6,567 200.1119 USD
Purchase 6,922 200.0934 USD
Purchase 7,137 201.7453 USD
Purchase 8,422 199.8021 USD
Purchase 12,974 201.2478 USD
Purchase 18,337 202.4577 USD
Purchase 32,305 201.3094 USD
Purchase 39,748 203.1446 USD
Sale 2 203.4300 USD
Sale 11 202.6472 USD
Sale 25 201.4100 USD
Sale 45 202.9550 USD
Sale 65 199.5500 USD
Sale 100 202.8500 USD
Sale 106 203.0177 USD
Sale 122 202.9150 USD
Sale 194 202.6825 USD
Sale 198 203.5638 USD
Sale 200 201.7950 USD
Sale 200 203.3125 USD
Sale 200 202.9800 USD
Sale 259 202.8301 USD
Sale 300 203.3650 USD
Sale 425 202.8407 USD
Sale 1,256 203.1103 USD
Sale 1,927 203.1284 USD
Sale 2,902 202.1232 USD
Sale 4,242 200.1138 USD
Sale 6,712 201.7083 USD
Sale 6,717 201.6243 USD
Sale 6,792 200.8114 USD
Sale 7,229 199.2300 USD
Sale 8,542 203.0101 USD
Sale 9,136 203.2162 USD
Sale 9,586 203.1582 USD
Sale 9,822 203.2203 USD
Sale 16,213 202.3648 USD
Sale 29,693 201.5101 USD
Sale 30,000 199.9878 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing
and any other person relating to the voting rights of any relevant securities under any option
referred to on this form or relating to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred to on this form is referenced. If none, this
should be stated.
NONE
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 14 Jan 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210114005490/en/
(https://www.businesswire.com/news/home/20210114005490/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Gym Group PLC (The) Barclays PLC - Holding(s) in Company
AnnouncementREG - Entain PLC Barclays PLC - TR1: Notification of Major Holdings
AnnouncementREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
Announcement